Institute of Innovative Research, 
Tokyo Institute of Technology.


Press Release

Efficient Boron Neutron Capture Therapy for Brain Tumor with Novel Boron Carrier

A new boron agent drastically improves the effectiveness of boron neutron capture therapy for glioblastoma, demonstrate researchers at Tokyo Tech. The agent is selectively absorbed by brain tumor cells, exhibits enhanced blood retention, and can be administered at low doses. Experiments on cell cultures, mice, and rats show promising results, highlighting the potential of the novel agent for radiotherapy.